Table 2.
Clinical | Lab | US | CT | MRI | |
---|---|---|---|---|---|
Cystitis |
Gender: M<F. Most common symptoms: dysuria, frequency, urgency, hematuria. Etiology: Infectious (Bacterial, Tuberculosis, Viral, Fungal). Noninfectious (mechanical, drug-related, radiation-induced). |
Leukocyturia, bacteriuria, pyuria, hematuria | Hypoechoic edematous bladder wall. | Usually entire bladder wall thickening +/− hypodense wall. Emphysematous cystitis: gas in the bladder wall and/or lumen. | |
Non-distention and Trabeculation | Indistinguishable by imaging alone | ||||
Bladder Carcinoma |
Demographics: 50–60 years of age. Gender: M:F = 4:1 5 year survival rate: 82% in all stages combined. Most common symptom: painless hematuria. |
Positive urine dipstick. +/− Micro to normocytic anemia. | Hypo to normoechoic bladder wall thickening or endoluminal soft tissue mass. | Sessile or pedunculated soft tissue mass projecting into the lumen, with similar density to bladder wall. Fine punctate calcifications with tumour. +/− Enlarged metastatic lymph nodes. +/− Extravesical tumour extension. |
T1WI: Tumour has intermediate signal intensity, equal to muscle layer of bladder wall. Infiltration of perivesical fat has high signal intensity. T1 C+: Mild early enhancement in primary, perivesical, nodal or bone invasion. +/− Enlarged metastatic lymph nodes. T2WI: Tumour has intermediate signal intensity, higher than bladder wall and lower than urine. Infiltration of perivesical fat has either low or high signal intensity. |
Blood Clot | Frequently post-trauma. | Mobile mass, does not cast an acoustical shadow. | Disappear with time, no enhancement | Low signal intensity, no infiltration. | |
Extrinsic tumour | Rectal, ovarian, vaginal, uterus tumours or fibrosis overlying bladder may simulate bladder wall thickening, mimicking neoplastic involvement. |